BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27397095)

  • 1. Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
    Adejoro O; Alishahi A; Konety B
    Urology; 2016 Nov; 97():130-137.e1. PubMed ID: 27397095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
    Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
    Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of perioperative blood transfusion on mortality for major urologic malignancies.
    Soubra A; Zabell JR; Adejoro O; Konety BR
    Clin Genitourin Cancer; 2015 Jun; 13(3):e173-81. PubMed ID: 25600760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall survival advantage with partial nephrectomy: a bias of observational data?
    Shuch B; Hanley J; Lai J; Vourganti S; Kim SP; Setodji CM; Dick AW; Chow WH; Saigal C;
    Cancer; 2013 Aug; 119(16):2981-9. PubMed ID: 23674264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary 90-day mortality rates after radical cystectomy in the elderly.
    Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI
    Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
    Abdollah F; Sun M; Jeldres C; Schmitges J; Thuret R; Djahangirian O; Tian Z; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population based assessment of perioperative mortality after cystectomy for bladder cancer.
    Isbarn H; Jeldres C; Zini L; Perrotte P; Baillargeon-Gagne S; Capitanio U; Shariat SF; Arjane P; Saad F; McCormack M; Valiquette L; Peloquin F; Duclos A; Montorsi F; Graefen M; Karakiewicz PI
    J Urol; 2009 Jul; 182(1):70-7. PubMed ID: 19447427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life Expectancy and Variation in Treatment for Early Stage Kidney Cancer.
    Daskivich TJ; Tan HJ; Litwin MS; Hu JC
    J Urol; 2016 Sep; 196(3):672-7. PubMed ID: 27012644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urethrectomy following cystectomy for bladder cancer in men: practice patterns and impact on survival.
    Nelles JL; Konety BR; Saigal C; Pace J; Lai J;
    J Urol; 2008 Nov; 180(5):1933-6; discussion 1936-7. PubMed ID: 18801516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.
    Thomas C; Giesswein A; Hainz M; Stein R; Rubenwolf P; Roos FC; Neisius A; Nestler S; Hampel C; Jäger W; Wiesner C; Thüroff JW
    Int Urol Nephrol; 2015 Nov; 47(11):1789-96. PubMed ID: 26377495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
    Guo X; Liu M; Hou H; Liu S; Zhang X; Zhang Y; Wu P; Pang C; Wang J
    Int J Clin Oncol; 2019 Aug; 24(8):957-965. PubMed ID: 30903422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
    Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival.
    Bourgade V; Drouin SJ; Yates DR; Parra J; Bitker MO; Cussenot O; Rouprêt M
    World J Urol; 2014 Apr; 32(2):475-9. PubMed ID: 23455886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma.
    Meskawi M; Becker A; Bianchi M; Trinh QD; Roghmann F; Tian Z; Graefen M; Perrotte P; Karakiewicz PI; Sun M
    Int J Urol; 2014 Feb; 21(2):122-8. PubMed ID: 23819700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy.
    Froehner M; Koch R; Heberling U; Novotny V; Hübler M; Wirth MP
    Urol Oncol; 2017 Jan; 35(1):32.e17-32.e23. PubMed ID: 27519277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
    Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
    J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.